Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Asri Karya Lestari Tbk. (ASLI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Asri Karya Lestari Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Asri Karya Lestari Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Asri Karya Lestari Tbk. trades at Rp210 (market cap 1.22T, 25.66M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 846.8K 24h volume). The key difference: Asri Karya Lestari Tbk. is the larger of the two by market cap, and Asri Karya Lestari Tbk. is more actively traded (25.66M versus 846.8K). Which is the better fit depends on your goals.

ASLILABS
Market Cap
1.22T651.75B
Volume
25.66M846.8K
Lot
256.57K8.47K
Turnover
5.39B140.27M
Average Price
210.23165.65
Value
5.39B140.27M
Indicative Equilibrium Price
210168
Indicative Equilibrium Volume
4.18K50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASLI
View details
LABS
View details

About Asri Karya Lestari Tbk.

PT Asri Karya Lestari Tbk (‘the Entity’) was established as a limited liability company based on deed No. 05 on December 20, 2008 before Notary Syanti Hardiyanti, SH in Jakarta. The entity started its commercial operations in 2009

Read more on ASLI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS